News & Events

Dr Dennis Burton to Chair The Antibody Series 2023

  • Dennis Burton appointed conference Chairman and will develop the scientific programme for 2023
  • The Antibody Series 2022 was the largest antibody discovery and development conference, attracting an audience circa 3,500

Porto, Portugal – 16 January 2023: The Antibody Series (TAS), hosted by FairJourney Biologics S.A. (FJB), leader in the discovery and optimization of antibodies, today announced Dr Dennis Burton as Chairman for the 3rd edition of conference, taking place 6th – 8th September 2023 at Vidago Palace in Vidago, Portugal, with opening keynotes on a Douro River Cruise, on-route to the Palace.

Dr Burton is the Chair and Professor in the Department of Immunology & Microbiology and holds the James & Jessie Minor Chair in Immunology. He is the Scientific Director of the IAVI Neutralizing Antibody Center, Director of The Consortium for HIV/AIDS Vaccine Development (CHAVD) at Scripps Research, and a member of the Ragon Institute of MGH, MIT and Harvard, Boston, USA. As Chairman of The Antibody Series, Dr. Burton is set to compose a highly impactful programme of international speakers and scientific presentations covering cutting-edge advancements and novel ideas from within the antibody discovery and development field.

     

The conference, the biggest of its kind, will unite industry and academic leading experts over 3 days to participate in the exchange of knowledge and provide an opportunity for discussion with peers and world-renowned speakers that can provide inspiration and valuable practical insights. Select talks will be available to those joining the Live Stream event on LinkedIn, register here. To keep updated on speaker announcements, follow the official Antibody Series Linkedin Page.

António Parada, CEO of FairJourney Biologics commented: “We are extremely pleased and honoured to have Dr Dennis Burton join The Antibody Series 2023 committee as Chairman. Dr Burton brings a wealth of expertise and excellence in the antibody field, and we look forward to working alongside Dr Burton to deliver a spectacular TAS 2023 to the scientific community.”

About Dennis Burton

 

Dennis Burton is the Chair and Professor in the Department of Immunology & Microbiologyand holds the James & Jessie Minor Chair in Immunology.

He received his B.A.in Chemistry from Oxford University and his Ph.D.from Lund University, Sweden in physical biochemistry. He is the Scientific Director of the IAVI Neutralizing Antibody Center, Director of The Consortium for HIV/AIDS Vaccine Development (CHAVD) at Scripps Research, and a member of the Ragon Institute of MGH, MIT and Harvard, Boston, USA.

He has held many research grants from the NIH and has published more than 450 papers in scientific journals. He has received numerous awards including the Jenner Fellowship of the Lister Institute and a Fellowship in the American Academy of Microbiology. In 2022, in a list of Top Immunologists by Research.com, he placed 7th in the USA and 9th in the world.

His research is focused on infectious disease, in particular the interplay of antibodies and highly mutable viruses, notably HIV. He is interested in the potential of broadly neutralizing antibodies to inform vaccine design.

 

About FairJourney Biologics

FairJourney Biologics (“FJB”) is a leading biologics CRO, providing integrated services across antibody discovery, engineering, and production to global biopharma. Founded in 2012 and headquartered in Porto, FJB has grown to over 200 highly technically skilled employees today. The company operates a flexible, customer-oriented ‘one-stop shop’ approach to biologics development focused on quality, reliability, and partnership. The company’s significant expertise in phage display technology, combined with a diverse approach to generating both immune and naïve antibody libraries have contributed to a market leading 99%+ project success rate with 14 antibodies in clinical stages.

For more information visit: www.antibodyseries.com | www.fjb.pt

 

Vidago Palace

Vidago Palace is a long-revered as a spa retreat among Europe’s elite – who came to benefit from the famed mineral waters of Vidago – Vidago Palace is a legend reborn. First opened in 1910, Vidago Palace was created to provide its discerning clientele with rooms and facilities fit for a king. Surrounded by natural beauty, Vidago Palace is an outstanding luxury hotel in Portugal, the prefect venue for events and a proud member of Leading Hotel Venues of the World.

Among the most famous historic luxury hotels in Portugal, Vidago Palace is magnificent yet inviting, combining the grandeur of a palace with the warmth of a country home. Surrounded by mountains and 250 acres of mature woods and parkland, Vidago Palace enjoys a tranquil setting – perfect for an exclusive and unforgettable conference.

 

Learn more about us

FairJourney Biologics is a leading biologics CRO, providing integrated services across antibody discovery, engineering and production to global biopharma. The Company’s significant expertise in phage display technology, combined with a diverse approach to generating both immune and naïve antibody libraries have contributed to a market leading 99%+ project success rate.

Get in touch with us
This site uses cookies to provide you with a great user experience. By using our website, you accept our use of cookies.